Investors who lost money on Iovance Biotherapeutics, Inc. (IOVA) should contact Levi & Korsinsky about pending Class Action - IO

  • NEW YORK, June 13, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Iovance Biotherapeutics, Inc. ("Iovance" or the "Company") (NASDAQ: IOVA) of a class action securities lawsuit.